欧美大色I日本婷婷I操屄亚洲I国产精品久久久久永久免费看I免费电视剧网站I国内精品网站Ixxxx77777I三级动图I丁香九月激情综合I欧美A一Igogogo在线观看免费高清完整版I啪啪AV′I亚洲va男人天堂I日本xxxxavI免费网站色I超碰精品男人的天堂I国精产品一区一区三区有vaI国产综合久久777777麻豆

Welcome to Linuo Group!HomeBusiness License
  • CN

  • WeChat

  • Mobile Site

  • Search

力諾資訊

Hongjitang holds National Forum for Diagnosis and Treatment of Interstitial Lung Disease through the Integrated Approach of TCM and Western Medicine

2023.07.13

On July 9, the National Forum for Diagnosis and Treatment of Interstitial Lung Disease through the Integrated Approach of TCM and Western Medicine was held at Hongjitang.

Interstitial lung disease (ILD) is one of the four major respiratory diseases with rising prevalence worldwide. The newly founded Committee for Research on ILD Prevention and Treatment Technology unter Shandong Traditional Chinese Medicine Association (STCMA) shall serve as a platform for prescription sharing to improve the effectiveness of ILD treatment with TCM, meanwhile promoting the R&D of new TCM drugs and standardization of diagnosis and treatment of the disease.

During the forum, TCM experts had in-depth exchanges from different perspectives, such as the therapeutic status quo of interstitial lung diseases, epidemiology and medication administration, with focus on Jinbei Koufuye.

Jinbei Koufuye is a TCM product for the treatment of idiopathic pulmonary fibrosis. It shows great clinical efficacy and less adverse reactions, helping improve the life quality of patients. The Development of Jinbei Koufuye and its Application in Respiratory Diseases, a research project carried out by Hongjitang TCM Institute, won the first prize of the first Shandong Traditional Chinese Medicine Industry Science and Technology Award.